glp 1 compounding update Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide FDA proposes a new GLP-1

Preclinical research suggests that GLP1 receptors exist on bone cells such as osteoblasts and osteoclasts

Zepbound: nausea, diarrhea, vomiting, constipation, abdominal pain, upset stomach, injection site reactions, fatigue, hypersensitivity reactions, belching, hair loss, gastroesophageal reflux disease (GERD)

This article is for educational purposes only

patients should contact their GP surgery or pharmacist for replacement and guidance

Folli F, Finzi G, Manfrini R, et al

Additionally, their potential anti-inflammatory properties mediated by inhibition of key signaling pathways, could align well with the immunopathogenesis of PsD, as suggested by preclinical and clinical evidence supporting their broader immunomodulatory across a spectrum of rheumatological and dermatological conditions